期刊文献+

假肥大型肌营养不良患者血清肌酸激酶变化规律 被引量:13

Changes of serum creatine kinase levels in children with Duchenne muscular dystrophy
下载PDF
导出
摘要 目的假肥大型肌营养不良患者血清肌酸激酶随病程进展而不断变化。该研究旨在分析假肥大型肌营养不良患者血清肌酸激酶的变化规律。方法收集临床已确诊的假肥大型肌营养不良患者的血清,其中男性39例,女性1例,通过连续监测法测定血清肌酸激酶。结果假肥大型肌营养不良患者血清肌酸激酶在3—5岁达到峰值,以后随病程进展和年龄增加逐年下降,年均下降率为8.7%。结论假肥大型肌营养不良患者的血清肌酸激酶在3—5岁达到峰值,以后随年龄增加而逐年下降,这种变化规律可以反映肌纤维坏死速率和病程进展速度,评估治疗效果。 Objective Duchenne muscular dystrophy (DMD) usually occurs prior to 3 years old. The value of serum creatine kinase changes with clinical progression and age in patients with DMD. This study aimed to investigate the regularity in the changes of serum creatine kinase activities in children with DMD. Methods Peripheral blood samples were obtained from 40 children with DMD (ranged from 3-14 years). Serum creatine kinase levels were assayed by kinetic UV test. Results Serum creatine kinase level in the 40 DMD patients ( ranged from 2 595- 45 495 U/L) was remarkably higher than the reference value (35-174 U/L). The highest serum creatine kinase level (average: 27 750-31 173 U/L) was found in 3-5 years old patients. Mterwards, serum creatine kinase level decreased with clinical progression and age, with a yearly average rate of decline was 8.7%. Conclnsions Serum creatine kinase level reaches a peak between 3 and 5 years old and then reduces with increasing age in children with DMD. The characteristic changes of serum creatine kinase are suspected to reflect the rate of muscle decay.
出处 《中国当代儿科杂志》 CAS CSCD 2008年第1期35-37,共3页 Chinese Journal of Contemporary Pediatrics
关键词 假肥大型肌营养不良 血清肌酸激酶 变化 规律 儿童 Duchenne muscular dystrophy Serum creatine kinase Change Regularity Child
  • 相关文献

参考文献16

  • 1Biggar WD. Duchenne muscular dystrophy [ J ]. Pediatr Rev, 2006, 27(3) : 83-88.
  • 2Hoogerwaard EM, Ginjaar IB, Bakker E, de Visser M. Dystrophin analysis in carriers of Duchenne and Becker muscular dystrophy [J]. Neurology, 2005, 65(12): 1984-1986.
  • 3Pearce JM. Early observations on duchenne-meryon muscular dystrophy [J]. Eur Neurol, 2005, 54( 1 ) : 46-48.
  • 4Griggs RC, Bushby K. Continued need for caution in the diagnosis of Duchenne muscular dystrophy [ J]. Neurology, 2005,64( 9): 1498-1499.
  • 5Roberts ML, Wells DJ, Graham IR, Fabb SA, Hill VJ, Duisit G, et al. Stable micro-dystrophin gene transfer using an integrating adeno-retroviral hybrid vector ameliorates the dystrophic pathology in mdx mouse tousle [ J ]. Hum Mol Genet, 2002, 11 ( 15 ) : 1719-1730.
  • 6樊绮诗,崔杰峰,夏玉卿,黄陶,孟渊,潘瑞福,李建平.多重聚合酶链反应检测DMD基因的初步分析[J].上海医学,2000,23(6):336-338. 被引量:5
  • 7吴志英,王柠,慕容慎行,林珉婷.单链构象多态技术检测脊髓性肌萎缩症基因缺失[J].中华神经科杂志,1998,31(5):289-291. 被引量:26
  • 8Giliberto F, Ferreiro V, Dalamon V, Suraee E, Cotignola J, Esperante S, et al. Direct deletion analysis in two Duehenne muscular dystrophy symptomatic females using polymorphic dinucleotide (CA) n loci within the dystrophin gene [J]. J Biochem Mol Biol, 2003, 36(2) : 179-184.
  • 9Nakae Y, Stoward PJ, Kashiyama T, Shono M, Akaqi A, Matsuzaki T, et al. Early onset of lipofusein accumulation in dystrophin-defieient skeletal muscles of DMD patients and mdx mice [J]. J Mol Histol, 2004, 35(5) : 489-499.
  • 10Schwartz M, Duno M. Multiplex ligation-dependent probe amplification is superior for detecting deletions/duplications in Duchenne muscular dystrophy [J]. Clin Genet, 2005,67(2) : 189-191.

二级参考文献15

  • 1潘晓丽,武盈玉.Duchenne型肌营养不良产前诊断的研究进展[J].中国优生与遗传杂志,1995,3(4):118-121. 被引量:1
  • 2Chang J G,Am J Hum Genet,1995年,57卷,1503页
  • 3王柠,临床神经病学杂志,1995年,8期,69页
  • 4陈碧芬,中华病理学杂志,1991年,20卷,38页
  • 5潘跃成,神经遗传病学通讯,1998年,1卷,18页
  • 6Sinha S,Clin Genet,1996年,50卷,327页
  • 7Ishitobi M, Haginoya K, Zhao Y, Ohnuma A, Minato J, Yanagisawa T, et al. Elevated plasma levels of transforming growth factor-β1 in patients with muscular dystrophy [ J ]. Neuroreport,2000, 11(18): 4033-4035.
  • 8Toepfer M, Fischer P, Abicht A, Lochmuller H, Porgratz D,Muller-Felber W. Localization of transforming growth factor-β in association with neuromuscular junctions in adult human muscle [J]. Cell Mol Neurobiol, 1999, 19(2): 297-300.
  • 9Melone MA, Peluso G, Petillo O, Galderisi U, Cotrufo R. Defective growth in vitro of Duchenne Muscular Dystrophy myoblasts: the molecular and biochemical basis [J]. J Cell Biochem,1999, 76(1): 118- 132.
  • 10Yamazaki M, Minota S, Sakurai H, Miyzono K, Yamada A,Kanazawa I, et al. Expression of transforming growth factor-beta 1 and its relation to endomysial fibrosis in progressive muscular dystrophy [J]. Am J Pathol, 1994, 144(2): 221-226.

共引文献30

同被引文献76

引证文献13

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部